Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSUAGE Protocol for Regadenoson Stress MPI
NCT01655524Phase 4Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminophylline in coronary artery disease (CAD), sponsored by Rush University Medical Center. Planned start Jul 2012; status: withdrawn.
02
Drugs
aminophylline
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01655524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655524.